Skip to content

A clinical trial comparing two different modes of blood purification in patients with recent onset kidney shut down due to some illness

Comparing intermittent online hemodiafiltration and conventional intermittent hemodialysis in patients with AKI and SIRS, a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009675
Enrollment
80
Registered
2017-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute kidney injury patients requiring renal replacement therapy

Interventions

Intervention1: Online intermittent hemodiafiltration: This is a type of dialysis machine which involves both convective and diffusive clearances. Control Intervention1: Conventional intermittent hemod

Sponsors

PGIMER chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. AKI stage 3 of KDIGO classification or Acute on CKD patients fulfilling standard criteria for requirement of renal replacement therapy 2. Presence of SIRS, fulfilling at least 2 out of 4 criteria

Exclusion criteria

Exclusion criteria: 1. Patients with hypotension requiring more than single inotropes 2. CKD and post renal transplant patients already on some form of renal replacement therapy 3. Indication of dialysis, toxin or drug removal 4. AKI patients with suspected or confirmed Glomerulonephritis, vasculitis or obstructive AKI 5. Terminal illness with associated life expectancy less than 2 months

Design outcomes

Primary

MeasureTime frame
1. To examine the feasibility of conducting a larger study that will determine whether convective clearance confers improved outcome as compare to diffusive clearance using intermittent modes of RRT 2. To compare outcome in terms of renal recovery in patients with AKI and SIRS, undergoing online hemodiafiltration vs conventional hemodialysisTimepoint: 1 month

Secondary

MeasureTime frame
Change in body fluid levels as assessed by bioimpedance machineTimepoint: 7 days;Change in qSOFA scoreTimepoint: 7 days;Change in serum cytokine concentration (IL6)Timepoint: 7 days;Mortality benefit Timepoint: 1 month

Countries

India

Contacts

Public ContactSaurabh nayak

PGIMER, Chandigarh

saurabhnayak2012@gmail.com9878943178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026